Adial Pharmaceuticals WT EXP 073123 Statistics Share Statistics Adial Pharmaceuticals WT EXP 073123 has n/a
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information Short Interest n/a Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) n/a
Valuation Ratios The PE ratio is -1.42 and the forward
PE ratio is null.
Adial Pharmaceuticals WT EXP 073123's PEG ratio is
0.02.
PE Ratio -1.42 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 4.62 P/FCF Ratio -2.71 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Adial Pharmaceuticals WT EXP 073123.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.16,
with a Debt / Equity ratio of 0.
Current Ratio 4.16 Quick Ratio 4.16 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0, so Adial Pharmaceuticals WT EXP 073123's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 0.02 200-Day Moving Average 0.17 Relative Strength Index (RSI) 39.3 Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit n/a Operating Income -8.28M Net Income -13.2M EBITDA -8.28M EBIT n/a Earnings Per Share (EPS) -0.71
Full Income Statement Balance Sheet The company has 3.75M in cash and 0 in
debt, giving a net cash position of 3.75M.
Cash & Cash Equivalents 3.75M Total Debt n/a Net Cash n/a Retained Earnings -82M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -6.92M
and capital expenditures 0, giving a free cash flow of -6.92M.
Operating Cash Flow -6.92M Capital Expenditures n/a Free Cash Flow -6.92M FCF Per Share -0.37
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
